Cubist Systematic Strategies’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Buy |
+171,561
| New | +$349K | ﹤0.01% | 1115 |
|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$6.12K | – | 2501 |
|
|
2023
Q4 | $6.12K | Buy |
1,000
+497
| +99% | +$3.04K | ﹤0.01% | 1990 |
|
|
2023
Q3 | $2.35K | Buy |
+503
| New | +$2.35K | ﹤0.01% | 1868 |
|
|
2023
Q2 | – | Sell |
-9,929
| Closed | -$97.7K | – | 2630 |
|
|
2023
Q1 | $97.7K | Sell |
9,929
-12,555
| -56% | -$124K | ﹤0.01% | 2415 |
|
|
2022
Q4 | $421K | Sell |
22,484
-13,179
| -37% | -$247K | ﹤0.01% | 2282 |
|
|
2022
Q3 | $738K | Buy |
+35,663
| New | +$738K | ﹤0.01% | 2270 |
|
|
2022
Q1 | – | Sell |
-5,307
| Closed | -$318K | – | 3630 |
|
|
2021
Q4 | $318K | Buy |
5,307
+5,099
| +2,451% | +$306K | ﹤0.01% | 2754 |
|
|
2021
Q3 | $18K | Buy |
+208
| New | +$18K | ﹤0.01% | 2891 |
|
|
2021
Q2 | – | Sell |
-2,443
| Closed | -$272K | – | 2991 |
|
|
2021
Q1 | $272K | Buy |
2,443
+1,765
| +260% | +$197K | ﹤0.01% | 2315 |
|
|
2020
Q4 | $72K | Sell |
678
-2,957
| -81% | -$314K | ﹤0.01% | 2435 |
|
|
2020
Q3 | $506K | Buy |
+3,635
| New | +$506K | 0.01% | 1738 |
|
|
2020
Q1 | – | Sell |
-1,042
| Closed | -$41K | – | 2287 |
|
|
2019
Q4 | $41K | Buy |
+1,042
| New | +$41K | ﹤0.01% | 2291 |
|
|
2019
Q3 | – | Sell |
-2,734
| Closed | -$96K | – | 2325 |
|
|
2019
Q2 | $96K | Buy |
2,734
+1,596
| +140% | +$56K | ﹤0.01% | 2238 |
|
|
2019
Q1 | $51K | Sell |
1,138
-440
| -28% | -$19.7K | ﹤0.01% | 2102 |
|
|
2018
Q4 | $76K | Buy |
+1,578
| New | +$76K | ﹤0.01% | 1805 |
|
|
2018
Q2 | – | Sell |
-1,695
| Closed | -$96K | – | 1905 |
|
|
2018
Q1 | $96K | Buy |
+1,695
| New | +$96K | 0.01% | 1598 |
|
|
2015
Q4 | – | Sell |
-3,338
| Closed | -$232K | – | 1843 |
|
|
2015
Q3 | $232K | Buy |
+3,338
| New | +$232K | 0.01% | 1388 |
|